biotech company developing antibiotics against multi-drug resistant bacteria
smartbax has raised €1.2M across 1 funding round from 2 investors, most recently a Seed round in May 2023. Based in Munich, Germany; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-23 | Seed | €1.2M |
| Boehringer Ingelheim Venture Fund (BIVF),High-Tech Gründerfonds (HTGF) |
| View deal → |
